J&J gets out of diagnostics

Share this article:

Johnson & Johnson is offloading its Ortho Diagnostics business for $4 billion. The company announced Monday that it accepted the Carlyle Group's January offer to take on the business, which includes in-vitro diagnostic products.

Bloomberg reports that Carlyle expects to run the unit as a standalone business, and that the transaction relieves J&J of its only diagnostics division.

Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Novartis apologizes for slow reporting

Novartis is apologizing to Japan after the Ministry of Health, Labor and Welfare said the company had dragged its feet reporting adverse events for two of its cancer drugs.

J&J pulls morcellator from market

The company is calling the move a withdrawal, as opposed to a recall.

Pfizer buys two Baxter vaccines

The meningitis and encephalitis medications earned a combined $300 million last year.